VPH is an international community driving the adoption of in silico medicine by connecting scientists, industry, clinicians, patients, healthcare providers, regulators, and policymakers for a better and more efficient healthcare.
Countries involved
Institutions involved
Members
Discover more
During the closing ceremony of its 2026 Conference, VPH announced its largest-ever Young Scientists Committee, which will begin its two-year mandate in January 2027, strengthening opportunities for engagement, support, and representation of early-career researchers.
The VPH 2026 Conference was a celebration not only of scientific advances, but also of the people driving the future of in silico medicine. During the Awards Ceremony in Milan, we recognised outstanding contributions from early-career researchers across our community, celebrating their research, creativity and commitment to advancing the field.
It is with great sadness that we mourn the passing of Professor Reinhard Schneider, a distinguished scientist, colleague and valued member of the VPH Community.
